7-64521933-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178558.5(ZNF680):āc.821C>Gā(p.Ala274Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000707 in 1,612,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178558.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF680 | NM_178558.5 | c.821C>G | p.Ala274Gly | missense_variant | 4/4 | ENST00000309683.11 | NP_848653.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF680 | ENST00000309683.11 | c.821C>G | p.Ala274Gly | missense_variant | 4/4 | 1 | NM_178558.5 | ENSP00000309330 | P1 | |
ZNF680 | ENST00000476563.1 | n.762C>G | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151414Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000881 AC: 22AN: 249610Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 135026
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1460788Hom.: 0 Cov.: 34 AF XY: 0.0000647 AC XY: 47AN XY: 726678
GnomAD4 genome AF: 0.000125 AC: 19AN: 151414Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 73932
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.821C>G (p.A274G) alteration is located in exon 4 (coding exon 4) of the ZNF680 gene. This alteration results from a C to G substitution at nucleotide position 821, causing the alanine (A) at amino acid position 274 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at